• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-107作为一种候选抑癌基因在涉及多个基因的肾透明细胞癌中发挥作用。

microRNA-107 functions as a candidate tumor suppressor gene in renal clear cell carcinoma involving multiple genes.

作者信息

Song Nan, Ma Xin, Li Hongzhao, Zhang Yu, Wang Xiaoxiong, Zhou Pingkun, Zhang Xu

机构信息

Department of Urology, Chinese PLA General Hospital, Beijing, China.

Department of Radiation Toxicology and Oncology, Beijing Institute of Radiation Medicine, Beijing, China.

出版信息

Urol Oncol. 2015 May;33(5):205.e1-11. doi: 10.1016/j.urolonc.2015.02.003. Epub 2015 Mar 7.

DOI:10.1016/j.urolonc.2015.02.003
PMID:25758424
Abstract

BACKGROUND

MicroRNAs (miRNAs) are small RNAs with oncogenic and tumor-suppressing functions in cancer. miRNAs not only regulate various target genes but also participate in vital signaling pathways.

METHODS AND RESULTS

The tumor-suppressing function of miRNA-107 (miR-107) was confirmed in clear cell renal cell carcinoma in 52 paired clinical specimens and renal cell carcinoma cell lines. Significant correlations were noted between clinical features and miR-107 expression level. Lentiviral vector and biosynthesis mimics were used to overexpress pre-miR-107 or mimicked miR-107 to investigate further the tumorigenesis of miR-107 in vivo and in vitro. Cell proliferation and invasiveness were inhibited in the 786-O cell line after miR-107 was delivered. High miR-107 level expression can apparently induce cell cycle arrest at the G2/M phase and retard tumor growth in nude mice. In addition, eukaryotic translation initiation factor 5 was found to be a direct target of miR-107 and exhibited an inverse relationship with miR-107. It was seen that p53 and VHL genes, which are implicated in renal tumors, were associated with miR-107.

CONCLUSION

In summary, our results showed that miR-107 can inhibit cell proliferation and invasiveness of renal cell carcinoma. Furthermore, this study may provide a potential therapeutic regimen for clear cell renal cell carcinoma treatment.

摘要

背景

微小RNA(miRNA)是一类在癌症中具有致癌和抑癌功能的小RNA。miRNA不仅调控各种靶基因,还参与重要的信号通路。

方法与结果

在52对临床标本和肾癌细胞系中证实了miRNA - 107(miR - 107)在透明细胞肾细胞癌中的抑癌功能。临床特征与miR - 107表达水平之间存在显著相关性。使用慢病毒载体和生物合成模拟物过表达前体miR - 107或模拟miR - 107,以进一步研究miR - 107在体内和体外的肿瘤发生情况。在递送miR - 107后,786 - O细胞系中的细胞增殖和侵袭能力受到抑制。高miR - 107水平表达明显可诱导细胞周期停滞在G2/M期,并延缓裸鼠肿瘤生长。此外,发现真核翻译起始因子5是miR - 107的直接靶标,且与miR - 107呈负相关。可见参与肾肿瘤的p53和VHL基因与miR - 107有关。

结论

总之,我们的结果表明miR - 107可抑制肾细胞癌细胞的增殖和侵袭。此外,本研究可能为透明细胞肾细胞癌的治疗提供一种潜在的治疗方案。

相似文献

1
microRNA-107 functions as a candidate tumor suppressor gene in renal clear cell carcinoma involving multiple genes.微小RNA-107作为一种候选抑癌基因在涉及多个基因的肾透明细胞癌中发挥作用。
Urol Oncol. 2015 May;33(5):205.e1-11. doi: 10.1016/j.urolonc.2015.02.003. Epub 2015 Mar 7.
2
MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.微小 RNA-218 通过靶向参与黏着斑通路的窖蛋白-2 抑制肾细胞癌中的细胞迁移和侵袭。
J Urol. 2013 Sep;190(3):1059-68. doi: 10.1016/j.juro.2013.02.089. Epub 2013 Feb 27.
3
MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.微小RNA-185通过直接靶向血管内皮生长因子A(VEGFA)抑制VHL基因失活的透明细胞肾细胞癌的细胞增殖并诱导细胞凋亡。
Urol Oncol. 2015 Apr;33(4):169.e1-11. doi: 10.1016/j.urolonc.2015.01.003. Epub 2015 Feb 17.
4
miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.微小RNA-221通过靶向金属蛋白酶组织抑制因子2促进肾细胞癌的增殖、迁移和侵袭。
Int J Clin Exp Pathol. 2015 May 1;8(5):5224-9. eCollection 2015.
5
miR-206 functions as a novel cell cycle regulator and tumor suppressor in clear-cell renal cell carcinoma.miR-206 在肾透明细胞癌中作为一种新型的细胞周期调控因子和肿瘤抑制因子发挥作用。
Cancer Lett. 2016 Apr 28;374(1):107-116. doi: 10.1016/j.canlet.2016.01.032. Epub 2016 Jan 22.
6
miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.miR-192、miR-194 和 miR-215:抑制肾细胞癌肿瘤进展的汇聚 miRNA 网络。
Carcinogenesis. 2013 Oct;34(10):2231-9. doi: 10.1093/carcin/bgt184. Epub 2013 May 28.
7
miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.miR-203通过靶向FGF2抑制肾癌细胞的增殖、迁移和侵袭。
Diagn Pathol. 2015 Apr 9;10:24. doi: 10.1186/s13000-015-0255-7.
8
miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.miR-141 通过调控 EphA2 的表达来调控肾细胞癌的增殖和转移。
Clin Cancer Res. 2014 May 15;20(10):2617-30. doi: 10.1158/1078-0432.CCR-13-3224. Epub 2014 Mar 19.
9
miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.miR-28-5p通过靶向RAP1B发挥肾细胞癌肿瘤抑制因子的作用,具有多种抗肿瘤效应。
Oncotarget. 2016 Nov 8;7(45):73888-73902. doi: 10.18632/oncotarget.12516.
10
The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma.miR-17-92 簇在肾细胞癌中过度表达,并具有致癌作用。
J Urol. 2010 Feb;183(2):743-51. doi: 10.1016/j.juro.2009.09.086.

引用本文的文献

1
Decreased PANK1 expression in kidney renal clear cell carcinoma: impact on cell apoptosis, invasion, migration, and epithelial-mesenchymal transition.肾透明细胞癌中PANK1表达降低:对细胞凋亡、侵袭、迁移及上皮-间质转化的影响
Discov Oncol. 2024 Aug 28;15(1):380. doi: 10.1007/s12672-024-01251-2.
2
LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the β-catenin signaling pathway.LINC00662 通过竞争性结合 miR-107 并激活 β-catenin 信号通路促进黑色素瘤进展。
Int J Med Sci. 2024 Jan 1;21(2):265-276. doi: 10.7150/ijms.84072. eCollection 2024.
3
High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.
miR-107和miR-17的高表达预示急性髓系白血病预后不良并指导治疗选择。
Transl Cancer Res. 2023 Apr 28;12(4):913-927. doi: 10.21037/tcr-22-2484. Epub 2023 Mar 17.
4
Non-coding RNAs as Genetic Biomarkers for the Diagnosis, Prognosis, Radiosensitivity, and Histopathologic Grade of Meningioma.非编码RNA作为脑膜瘤诊断、预后、放射敏感性及组织病理学分级的遗传生物标志物
Cureus. 2023 Feb 3;15(2):e34593. doi: 10.7759/cureus.34593. eCollection 2023 Feb.
5
CircSLC7A6 promotes the progression of Wilms' tumor via microRNA-107/ ABL proto-oncogene 2 axis.环状 RNA SLC7A6 通过 microRNA-107/ABL 原癌基因 2 轴促进肾母细胞瘤的进展。
Bioengineered. 2022 Jan;13(1):308-318. doi: 10.1080/21655979.2021.2001204.
6
Circulating Exosomal MiR-107 Restrains Tumorigenesis in Diffuse Large B-Cell Lymphoma by Targeting 14-3-3η.循环外泌体 miR-107 通过靶向 14-3-3η 抑制弥漫性大 B 细胞淋巴瘤的肿瘤发生。
Front Cell Dev Biol. 2021 Apr 27;9:667800. doi: 10.3389/fcell.2021.667800. eCollection 2021.
7
The tRNA pseudouridine synthase TruB1 regulates the maturation of let-7 miRNA.tRNA 假尿嘧啶核苷合成酶 TruB1 调控 let-7 miRNA 的成熟。
EMBO J. 2020 Oct 15;39(20):e104708. doi: 10.15252/embj.2020104708. Epub 2020 Sep 14.
8
Inhibition of miR-22 enhanced the efficacy of icotinib plus pemetrexed in a rat model of non-small cell lung cancer.在非小细胞肺癌大鼠模型中,抑制miR-22增强了埃克替尼联合培美曲塞的疗效。
Iran J Basic Med Sci. 2020 Mar;23(3):329-336. doi: 10.22038/IJBMS.2019.39291.9320.
9
MicroRNA-107 is a novel tumor suppressor targeting POU3F2 in melanoma.微小 RNA-107 是一种新型的肿瘤抑制因子,靶向黑色素瘤中的 POU3F2。
Biol Res. 2020 Mar 14;53(1):11. doi: 10.1186/s40659-020-00278-3.
10
6mer Seed Toxicity in Viral microRNAs.病毒微小RNA中的6聚体种子毒性
iScience. 2020 Feb 21;23(2):100737. doi: 10.1016/j.isci.2019.11.031. Epub 2019 Dec 11.